Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» beloranib
beloranib
Zafgen starts comeback with first data on replacement weight loss drug
Fierce Biotech
Fri, 05/5/17 - 10:27 am
Zafgen
obesity
beloranib
ZGN-1061
In the Spirit of the Olympics: On and Off the Pharma Podium
PharmExec
Sat, 08/13/16 - 06:44 pm
Shire
Xiidra
Bayer
JNJ
beloranib
Zafgen
GSK
Valeant Pharmaceuticals
Zafgen shares drop more than 40% as drug focus shifted
Marketwatch
Tue, 07/19/16 - 10:05 pm
Zafgen
beloranib
ZGN-1061
obesity
Zafgen up 6% after weight loss drug has positive late-stage trial results
Marketwatch
Mon, 06/13/16 - 11:28 am
Zafgen
obesity
beloranib
diabetes
Zafgen Soars on Positive Phase 2 Results
24/7 Wall St
Thu, 02/18/16 - 09:42 am
Zafgen
clinical trials
beloranib
obesity
type 2 diabetes
Zafgen Surges as New Drug Findings May Help Restart FDA Review
Bloomberg
Thu, 01/21/16 - 09:40 am
Zafgen
FDA
beloranib
Zafgen Inc Surges on Positive One-Of-A-Kind Drug Trial Results
Bidness, ETC
Wed, 01/20/16 - 08:43 am
Zafgen
clinical trials
beloranib
Prader-Willi Syndrome
4 Top FDA Decisions Expected in Q1
24/7 Wall St
Mon, 01/4/16 - 10:05 am
FDA
Zafgen
beloranib
Biomarin
Peg-Pal
PB272
Puma Biotechnology
Aquinox
AQX-1125
FDA orders Zafgen to halt clinical trial for obesity drug
Boston Globe, MA
Thu, 12/3/15 - 09:51 pm
FDA
obesity
clinical trials
Zafgen
beloranib
Zafgen shares crash after second patient in pivotal obesity study dies
Fierce Biotech
Wed, 12/2/15 - 09:22 am
Zafgen
beloranib
obesity
Zafgen finally breaks its silence, says it's probing death of a patient
Fierce Biotech
Wed, 10/14/15 - 02:20 pm
Zafgen
Prader-Willi Syndrome
beloranib
Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
Yahoo
Wed, 09/9/15 - 08:05 am
Zafgen
beloranib
clinical trials
obesity
diabetes
Zafgen Announces New Weight Loss and Safety Data from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity at ENDO 2015
Yahoo
Sun, 03/8/15 - 10:18 am
Zafgen
hypothalamic injury-associated obesity
beloranib
Zafgen's promising obesity drug comes through in another midstage trial
Fierce Biotech
Wed, 01/7/15 - 09:23 am
Zafgen
obesity
beloranib
hypothalamic injury-associated obesity
You’ve got obesity all wrong: Zafgen CEO
CNBC
Tue, 08/19/14 - 01:44 pm
obesity
Zafgen
Pharma CEOs
beloranib
Zafgen Opens A New Front In Its Obesity Strategy: Prader-Willi Syndrome
Forbes
Thu, 01/16/14 - 09:27 am
obesity
Zafgen
Prader-Willi Syndrome
beloranib
The Weight Loss Drug Company Investors Need to Watch Out For
Motley Fool
Fri, 12/13/13 - 08:32 am
beloranib
Zafgen
Vivus
Arena Pharmaceuticals
Zafgen drug helps patients lose up to 24 pounds
Yahoo/Reuters
Fri, 11/15/13 - 08:42 am
Zafgen
beloranib
obesity
Is The Anti-Obesity Space Going To Get Crowded?
Seeking Alpha
Mon, 06/24/13 - 10:52 am
obesity
Arena Pharmaceuticals
Orexigen
Vivus
beloranib
Zagfen
Contrave
Belviq
Qsymia
Zafgen Says Obesity Drug Spurs Weight Loss in Study
Bloomberg
Sun, 06/23/13 - 11:07 am
Zafgen
obesity
weight loss
beloranib
Pages
1
2
next ›
last »